dc.contributor.author |
Yurttas, Can |
|
dc.contributor.author |
Berchtold, Susanne |
|
dc.contributor.author |
Bitzer, Michael |
|
dc.contributor.author |
Malek, Nisar Peter |
|
dc.contributor.author |
Lauer, Ulrich Manfred |
|
dc.date.accessioned |
2015-02-04T10:00:51Z |
|
dc.date.available |
2015-02-04T10:00:51Z |
|
dc.date.issued |
2014 |
|
dc.identifier.issn |
2324-8637 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/59101 |
|
dc.language.iso |
en |
en |
dc.publisher |
Mary Ann Liebert |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1089/humc.2013.127 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Pulsed Versus Continuous Application of the Prodrug 5-Fluorocytosine to Enhance the Oncolytic Effectiveness of a Measles Vaccine Virus Armed with a Suicide Gene |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20150115224006_01797 |
de_DE |
utue.publikation.seiten |
85-96 |
de_DE |
utue.personen.roh |
Yurttas, Can |
|
utue.personen.roh |
Berchtold, Susanne |
|
utue.personen.roh |
Malek, Nisar P. |
|
utue.personen.roh |
Bitzer, Michael |
|
utue.personen.roh |
Lauer, Ulrich M. |
|
dcterms.isPartOf.ZSTitelID |
Human Gene Therapy Clinical Development |
de_DE |
dcterms.isPartOf.ZS-Issue |
2 |
de_DE |
dcterms.isPartOf.ZS-Volume |
25 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |